Clinical trial
High-Dose Chemotherapy and Autologous Blood Cell Transplantation in Treating…
NCT00003068 · University of Arizona, Other · Completed
Key facts
| NCT number | NCT00003068 |
|---|---|
| Title | High-Dose Chemotherapy and Autologous Blood Cell Transplantation in Treating Patients With Primary, Locally Advanced, or Stage IV Breast Cancer |
| Official title | An Out Patient Dose Escalation Trial of High Dose Mitoxantrone, Thiotepa and Cyclophosphamide Plus Autologous Blood Cell Rescue and Amifostine Cytoprotection |
| Lead sponsor | University of Arizona, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Breast Cancer, Drug/Agent Toxicity by Tissue/Organ |
| Intervention type | Drug, Procedure |
| Interventions | amifostine trihydrate, cyclophosphamide, mitoxantrone hydrochloride, thiotepa, peripheral blood stem cell transplantation |
| Enrollment | 30 |
| Start date | Jun 1, 1997 |
| Completion | Nov 1, 2002 |
| First posted | Aug 2, 2004 |
| Last update posted | Jan 31, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: